Finally, Some Good News About Cancer – Dr. Cheng-Ho Jimmy Lin is the Chief Scientific Officer of Oncology, at Natera. Most recently, he led the clinical genomics program at the National Cancer Institute at the National Institutes of Health. He was part of one of the first clinical genomics labs in academia at Washington University in St. Louis and led the computational analyses of the first ever exome sequencing studies in cancer, including breast, colorectal, pancreatic, glioblastoma, medulloblastoma, and melanoma at Johns Hopkins. He has published in top academic journals, such as Science, Nature, and Cell, and has been an expert in national and international media outlets, such as The New York Times, Forbes, Bloomberg Businessweek, and The Washington Post.
